Gainers
- Opiant Pharma (NASDAQ:OPNT) stock increased by 112.9% to $20.22 during Monday's regular session. Trading volume for Opiant Pharma's stock is 1.0 million as of 12:30 EST. This is 7619.5% of its average full-day volume over the last 100 days. The company's market cap stands at $104.4 million. The company's, Q3 earnings came out today.
- NeuBase Therapeutics (NASDAQ:NBSE) stock rose 42.82% to $0.31. Trading volume for this security as of 12:30 EST is 770.7K, which is 603.7% of its average full-day volume over the last 100 days. The company's market cap stands at $9.9 million.
- PDS Biotechnology (NASDAQ:PDSB) shares moved upwards by 25.62% to $7.04. The current volume of 13.4 million shares is 5628.6% of PDS Biotechnology's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $200.2 million. The company's, Q3 earnings came out today.
- Clovis Oncology (NASDAQ:CLVS) shares moved upwards by 24.1% to $0.36. Trading volume for this security as of 12:30 EST is 14.7 million, which is 400.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $51.9 million. The company's, Q3 earnings came out 3 days ago.
- Cabaletta Bio (NASDAQ:CABA) stock moved upwards by 19.75% to $2.85. Trading volume for this security as of 12:30 EST is 838.1K, which is 41.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $82.6 million. The company's, Q3 earnings came out 2 days ago.
- Cassava Sciences (NASDAQ:SAVA) shares rose 17.37% to $44.13. As of 12:30 EST, this security is trading at a volume of 2.4 million shares, making up 73.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.7 billion.
Losers
- Satsuma Pharmaceuticals (NASDAQ:STSA) shares decreased by 83.5% to $0.67 during Monday's regular session. Satsuma Pharmaceuticals's stock is trading at a volume of 11.8 million shares as of 12:30 EST. This is 8578.9% of its average full-day volume over the last 100 days. The company's market cap stands at $22.1 million.
- SELLAS Life Sciences Gr (NASDAQ:SLS) shares decreased by 41.32% to $2.67. Trading volume for this security as of 12:30 EST is 1.7 million, which is 623.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $54.8 million. As per the news, the Q3 earnings report came out today.
- Nuwellis (NASDAQ:NUWE) stock declined by 38.46% to $0.12. As of 12:30 EST, this security is trading at a volume of 8.0 million shares, making up 237.0% of its average full-day volume over the last 100 days. The company's market cap stands at $3.8 million. As per the news, the Q3 earnings report came out 4 days ago.
- POINT Biopharma Global (NASDAQ:PNT) shares decreased by 34.85% to $5.96. Trading volume for this security as of 12:30 EST is 3.7 million, which is 510.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $619.4 million.
- MorphoSys (NASDAQ:MOR) shares decreased by 27.29% to $3.97. As of 12:30 EST, MorphoSys's stock is trading at a volume of 626.2K, which is 949.4% of its average full-day volume over the last 100 days. The company's market cap stands at $542.3 million.
- Stoke Therapeutics (NASDAQ:STOK) stock fell 27.23% to $9.09. The current volume of 616.0K shares is 248.0% of Stoke Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $358.3 million. As per the news, the Q3 earnings report came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
